Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.625 USD | +1.54% | +5.20% | -15.74% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 187M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 1.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
-357
x | P/E ratio 2025 * |
17.4
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.84% |
Latest transcript on Alimera Sciences, Inc.
1 day | +1.54% | ||
1 week | +5.20% | ||
Current month | -1.09% | ||
1 month | -3.70% | ||
3 months | -6.43% | ||
6 months | +7.06% | ||
Current year | -15.74% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 3.64 | +1.96% | 22 432 |
24-05-07 | 3.57 | -4.80% | 57,870 |
24-05-06 | 3.75 | +2.74% | 99,562 |
24-05-03 | 3.65 | +4.89% | 143,580 |
24-05-02 | 3.48 | +0.58% | 42,910 |
Delayed Quote Nasdaq, May 08, 2024 at 11:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.74% | 187M | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
-15.15% | 31.87B | |
+53.36% | 24.52B | |
-13.99% | 15.68B | |
-8.63% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- ALIM Stock